Identifying dose, mode of action, and adverse negative effects with our in vitro and in vivo platform

Our BioPharma Efficacy team specializes in the characterization of monoclonal antibodies, hormones, and cytokines. We also have extensive experience working with biosimilars or modified biologics, such as pegylated products.

Cell Based Analysis

In Vitro cGMP Potency
Evaluation

End-to-end potency testing from early development to routine batch releases

Functional
Assays

Assess biological response using a wide variety of in vitro cell-based readouts customized depending on the drug mode of action

Ligand Binding
Assays

Quantify drug-target interaction via ELISA or flow cytometry

Learn More

In vivo Testing

Our trained scientists can perform a variety of specialized analyses using
our in vivo models to evaluate the efficacy and safety of your agent.

Evaluate direct organ function

Obtain full hematology insights

Test renal tissue
functionality

Investigate biomarkers level by ELISA (Kim-1, NGAL, NAG)

Quantify ligand binding activity on peripheral blood or tissue by FACS

Evaluate immune activation with multiplexed cytokine analysis

Detect and profile pro-inflammatory cells

Assess renal tissue macrophages infiltration

 

Your Development Partner

Contact Us

Contact us to learn more about our assay development and testing services and how we can help you bring safe and effective drug products and biologics to market.

X

NEWS RELEASE

Bioassay GmbH now part of Reaction Biology Corporation.

Read more